Case Study
Leveraging ADVASEPT® Technology
Catalent’s ADVASEPT® Technology is an advanced aseptic manufacturing process that leverages blow-fill-seal (BFS) technology to create a glass free container closure that drastically reduces the risk of foreign particulates and microbial contamination. This technology allows the freedom to create a new primary container that meets the needs required for global vaccine distribution. BFS has been used for over 20 years for commercial biologic drug products and Catalent recently completed a direct comparison between a model mAb filled in glass vials and ADVASEPT® Vials. Learn more today.
